Active Ingredient(s):Dupilumab FDA Approved: * March 28, 2017 Pharm Company: *REGENERON PHARMACEUTICALS Category:Skin Care
Dupilumab, sold under the brand name Dupixent, is a monoclonal antibody blocking interleukin 4 and interleukin 13, used for allergic diseases such as eczema (atopic dermatitis), asthma and nasal polyps which result in chronic sinusitis.
Side effects include decreased levels of T helper cells, cold sores, allergic reactions and inflammation of the cornea. It was developed by Regeneron Pharmaceuticals...
* May have multiple approval dates, manufacturers, or labelers.